BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18694392)

  • 21. Nomad Biosensors: A New Multiplexed Technology for the Screening of GPCR Ligands.
    Mella RM; Kortazar D; Roura-Ferrer M; Salado C; Valcárcel M; Castilla A; Villacé P
    SLAS Technol; 2018 Jun; 23(3):207-216. PubMed ID: 29412765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplexed G-protein-coupled receptor Ca2+ flux assays for high-throughput screening.
    Miret JJ; Zhang J; Min H; Lewis K; Roth M; Charlton M; Bauer PH
    J Biomol Screen; 2005 Dec; 10(8):780-7. PubMed ID: 16234348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GPCR assay automation for leveraging lead optimization.
    Cvijic ME; Chen J; Kubala S; Nolfo J; Kolodin G; Zhang L
    J Lab Autom; 2012 Aug; 17(4):266-74. PubMed ID: 22505604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ultra-HTS process for the identification of small molecule modulators of orphan G-protein-coupled receptors.
    Cacace A; Banks M; Spicer T; Civoli F; Watson J
    Drug Discov Today; 2003 Sep; 8(17):785-92. PubMed ID: 12946641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening.
    Eglen R; Reisine T
    Assay Drug Dev Technol; 2011 Apr; 9(2):108-24. PubMed ID: 21186936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a generic dual-reporter gene assay for screening G-protein-coupled receptors.
    Kent TC; Thompson KS; Naylor LH
    J Biomol Screen; 2005 Aug; 10(5):437-46. PubMed ID: 16093553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G-protein coupled receptor assays: to measure affinity or efficacy that is the question.
    Williams C; Sewing A
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):285-92. PubMed ID: 16101004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Label-free optical biosensor: a tool for G protein-coupled receptors pharmacology profiling and inverse agonists identification.
    Lee PH
    J Recept Signal Transduct Res; 2009; 29(3-4):146-53. PubMed ID: 19594401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CellCard System: a novel approach to assessing compound selectivity for lead prioritization of G protein-coupled receptors.
    Beske O; Goldbard S; Turpin P
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):293-9. PubMed ID: 16101005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confocal fluorescence microscopy for high-throughput screening of G-protein coupled receptors.
    Heilker R; Zemanova L; Valler MJ; Nienhaus GU
    Curr Med Chem; 2005; 12(22):2551-9. PubMed ID: 16248815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-cell biosensor for label-free detection of GPCR-mediated drug responses in personal cell lines.
    Hillger JM; Schoop J; Boomsma DI; Slagboom PE; IJzerman AP; Heitman LH
    Biosens Bioelectron; 2015 Dec; 74():233-42. PubMed ID: 26143464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible G Protein βγ9 Distribution-Based Assay Reveals Molecular Underpinnings in Subcellular, Single-Cell, and Multicellular GPCR and G Protein Activity.
    Senarath K; Ratnayake K; Siripurapu P; Payton JL; Karunarathne A
    Anal Chem; 2016 Dec; 88(23):11450-11459. PubMed ID: 27778511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards the miniaturization of GPCR-based live-cell screening assays.
    Martins SA; Trabuco JR; Monteiro GA; Chu V; Conde JP; Prazeres DM
    Trends Biotechnol; 2012 Nov; 30(11):566-74. PubMed ID: 22921755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput screening of interactions between G protein-coupled receptors and ligands using confocal optics microscopy.
    Zemanová L; Schenk A; Valler MJ; Nienhaus GU; Heilker R
    Methods Mol Biol; 2005; 305():365-84. PubMed ID: 15940007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cAMP Biosensor-Based High-Throughput Screening Assay for Identification of Gs-Coupled GPCR Ligands and Phosphodiesterase Inhibitors.
    Vedel L; Bräuner-Osborne H; Mathiesen JM
    J Biomol Screen; 2015 Aug; 20(7):849-57. PubMed ID: 25851033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing label-free biosensors for pharmacological screening with cell-based functional assays.
    Peters MF; Vaillancourt F; Heroux M; Valiquette M; Scott CW
    Assay Drug Dev Technol; 2010 Apr; 8(2):219-27. PubMed ID: 20085460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CRE luc bioluminescence transgenic mouse model for detecting ligand activation of GPCRs.
    Dressler H; Economides K; Favara S; Wu NN; Pang Z; Polites HG
    J Biomol Screen; 2014 Feb; 19(2):232-41. PubMed ID: 23896687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of high-throughput screening to novel lead discovery.
    Kenny BA; Bushfield M; Parry-Smith DJ; Fogarty S; Treherne JM
    Prog Drug Res; 1998; 51():245-69. PubMed ID: 9949864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reporter assay for G-protein-coupled receptors using a B-cell line suitable for stable episomal expression.
    Saeki S; Kunitomo H; Narita Y; Mimura H; Nishi T; Sasaki K
    Anal Biochem; 2010 May; 400(2):163-72. PubMed ID: 20122890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.